Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
The Journal of Allergy and Clinical Immunology|December 9, 2014
Dupilumab improves the molecular signature in skin of patients with moderate-to-severe atopic dermatitisJennifer D Hamilton, Mayte Suárez-Fariñas, Nikhil Dhingra, et al.
Neuroimage|April 22, 2010
Quantification of cerebral cannabinoid receptors subtype 1 (CB1) in healthy subjects and schizophrenia by the novel PET radioligand [11C]OMARDean F Wong, Hiroto Kuwabara, Andrew G Horti, et al.
Advances in Therapy|September 24, 2020
Bioequivalence Study Comparing Fixed-Dose Combination of Clopidogrel and Aspirin with Coadministration of Individual Formulations in Chinese Subjects Under Fed Conditions: A Phase I, Open-Label, Randomized, Crossover StudyYan Li, Jeffrey E Ming, Fangyuan Kong, et al.
The New England Journal of Medicine|May 22, 2013
Dupilumab in persistent asthma with elevated eosinophil levelsSally Wenzel, Linda Ford, David Pearlman, et al.
Clinical Pharmacology in Drug Development|April 30, 2020
Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Dupilumab in Healthy Adult SubjectsZhaoyang Li, Allen Radin, Meng Li, et al.
Nature Communications|July 15, 2022
AMEERA-1 phase 1/2 study of amcenestrant, SAR439859, in postmenopausal women with ER-positive/HER2-negative advanced breast cancerAditya Bardia, Sarat Chandarlapaty, Hannah M Linden, et al.
Molecular Cytogenetics|May 13, 2008
Expanding the clinical phenotype of the 3q29 microdeletion syndrome and characterization of the reciprocal microduplicationBlake C Ballif, Aaron Theisen, Justine Coppinger, et al.
Human Genetics|October 18, 2002
Absence of PTPN11 mutations in 28 cases of cardiofaciocutaneous (CFC) syndromeAndra Ion, Marco Tartaglia, Xiaoling Song, et al.
Gene Regulation and Systems Biology|August 15, 2017
A Quantitative Systems Pharmacology Platform to Investigate the Impact of Alirocumab and Cholesterol-Lowering Therapies on Lipid Profiles and Plaque CharacteristicsJeffrey E Ming, Ruth E Abrams, Derek W Bartlett, et al.
The New England Journal of Medicine|July 10, 2014
Dupilumab treatment in adults with moderate-to-severe atopic dermatitisLisa A Beck, Diamant Thaçi, Jennifer D Hamilton, et al.
Pageof 4